Macrophage Diversity Enhances Tumor Progression and Metastasis

被引:4108
作者
Qian, Bin-Zhi [1 ]
Pollard, Jeffrey W. [1 ,2 ,3 ]
机构
[1] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Cooperat Ctr Study Reprod & Infertil Res, Bronx, NY 10461 USA
基金
美国国家卫生研究院;
关键词
COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; GENE-EXPRESSION ANALYSIS; LYMPH-NODE METASTASIS; MYELOID CELLS; PROMOTE TUMOR; MOUSE MODEL; ANGIOGENIC SWITCH;
D O I
10.1016/j.cell.2010.03.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is persuasive clinical and experimental evidence that macrophages promote cancer initiation and malignant progression. During tumor initiation, they create an inflammatory environment that is mutagenic and promotes growth. As tumors progress to malignancy, macrophages stimulate angiogenesis, enhance tumor cell migration and invasion, and suppress antitumor immunity. At metastatic sites, macrophages prepare the target tissue for arrival of tumor cells, and then a different subpopulation of macrophages promotes tumor cell extravasation, survival, and subsequent growth. Specialized subpopulations of macrophages may represent important new therapeutic targets.
引用
收藏
页码:39 / 51
页数:13
相关论文
共 131 条
  • [1] Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma
    Abraham, Dietmar
    Zins, Karin
    Sioud, Mouldy
    Lucas, Trevor
    Schaefer, Romana
    Stanley, E. Richard
    Aharinejad, Seyedhossein
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (06) : 1339 - 1352
  • [2] Aharinejad Seyedhossein, 2009, V487, P243, DOI 10.1007/978-1-60327-547-7_12
  • [3] Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice
    Almholt, K
    Lund, LR
    Rygaard, J
    Nielsen, BS
    Dano, K
    Romer, J
    Johnsen, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (04) : 525 - 532
  • [4] Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer
    Bailey, Charles
    Negus, Rupert
    Morris, Alistair
    Ziprin, Paul
    Goldin, Robert
    Allavena, Paola
    Peck, David
    Darzi, Ara
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (02) : 121 - 130
  • [5] Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    Balkwill, F
    Charles, KA
    Mantovani, A
    [J]. CANCER CELL, 2005, 7 (03) : 211 - 217
  • [6] Tumour necrosis factor and cancer
    Balkwill, Frances
    [J]. NATURE REVIEWS CANCER, 2009, 9 (05) : 361 - 371
  • [7] The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
    Beck, Andrew H.
    Espinosa, Inigo
    Edris, Badreddin
    Li, Rui
    Montgomery, Kelli
    Zhu, Shirley
    Varma, Sushama
    Marinelli, Robert J.
    van de Rijn, Matt
    West, Robert B.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (03) : 778 - 787
  • [8] Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
    Berg, DJ
    Davidson, N
    Kuhn, R
    Muller, W
    Menon, S
    Holland, G
    ThompsonSnipes, L
    Leach, MW
    Rennick, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) : 1010 - 1020
  • [9] The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
    Bingle, L
    Brown, NJ
    Lewis, CE
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (03) : 254 - 265
  • [10] A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
    Biswas, SK
    Gangi, L
    Paul, S
    Schioppa, T
    Saccani, A
    Sironi, M
    Bottazzi, B
    Doni, A
    Vincenzo, B
    Pasqualini, F
    Vago, L
    Nebuloni, M
    Mantovani, A
    Sica, A
    [J]. BLOOD, 2006, 107 (05) : 2112 - 2122